New Funding Opportunity: Radiation-Induced Immune Dysfunction (U01)

Leading Research to Understand, Treat, and Prevent Infectious, Immunologic, and Allergic Diseases          Visit us on the Web ​The NIAID Radiation and Nuclear Countermeasures Program (RNCP) supports extramural research to develop safe and effective radiation medical countermeasures for clinical use during a radiation public health emergency. We are pleased to present the following new funding opportunity: Radiation-Induced Immune Dysfunction (U01 Clinical Trial Not Allowed) RFA-AI-21-019 The purpose of this initiative is to investigate the effects of radiation exposure on the immune system and explore possible treatments for radiation-induced immune dysfunction. Research gaps exist in understanding the mechanisms of injury and repair with regard to radiation-induced immune system dysfunction, and these gaps must be addressed to better develop medical countermeasures (MCMs) for radiation exposure. Through this initiative, the RNCP will support development of animal models for immune-targeted radiation injuries, studies to better understand radiation impacts on the immune system (including immune system-mediated multi-organ injury), and identification of immune-specific pathways targeted by radiation, as well as biomarkers of exposure and mitigators/treatments that target immune-related radiation response pathways. Applications are due August 24, 2021, by 5:00 PM local time of applicant organization. Please address inquiries to the appropriate Agency Contacts listed in Section VII of the Funding Opportunity Announcement.   Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID). This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107